Fig. 1: Overview of stages.

The study included a maximum of three stages per drug cohort. After the first stage, feasibility was evaluated. If considered promising, the cohort proceeded to the second stage, to confirm feasibility in a larger cohort and to evaluate preliminary efficacy. After evaluation, the cohorts were either closed or continued to the implementation stage.